simvastatin has been researched along with Cataract in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, CN; Boman, K; Devereux, RB; Gohlke-Bärwolf, C; Greve, AM; La Cour, M; Okin, PM; Pedersen, T; Ray, S; Rossebø, A; Wachtell, K | 1 |
| Mahdavi-Fard, A; Nader, ND; Pourafkari, L | 1 |
| Dobrzynski, JM; Kostis, JB | 1 |
| Al-Ghoul, KJ; Cenedella, RJ; Kuszak, JR; Qin, S; Sexton, PS | 1 |
| Burghaus, L; Haupt, WF; Liu, W | 1 |
| MacDonald, JS | 1 |
| Haefeli, WE; Jick, H; Meier, CR; Schlienger, RG | 1 |
| Behrens-Baumann, W; Fieseler, HG; Seidel, D; Thiery, J; Wieland, E | 1 |
| Lehto, S; Leino, M; Pyörälä, K; Rantala, A | 1 |
| Behrens-Baumann, W; Thiery, J | 1 |
| Hockwin, O; Schmidt, J; Schmitt, C | 2 |
| Bocanegra, TS; Boccuzzi, SJ; Keegan, ME; Shapiro, DR; Walker, JF | 1 |
| Lundh, BL; Nilsson, SE | 1 |
| Alberts, AW; Bokelman, DL; Chen, J; Gerson, RJ; Greenspan, MD; MacDonald, JS; Rubin, LF; Yudkovitz, JB | 1 |
| Bach, LA; Cooper, ME; Jerums, G; O'Brien, RC | 1 |
| Kreisberg, R; Mantell, G; Miller, V; Shapiro, DR; Stein, E; Washington, L | 1 |
| Behrens-Baumann, W; Creutzfeldt, C; Morawietz, A; Seidel, D; Thiery, J | 1 |
| Alberts, AW; Bokelman, DL; Gerson, RJ; Kornbrust, DJ; MacDonald, JS; Majka, JA; Stubbs, RJ | 1 |
1 review(s) available for simvastatin and Cataract
| Article | Year |
|---|---|
Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors.
Topics: Animals; Cataract; Dogs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Male; Necrosis; Rabbits; Rats; Simvastatin; Species Specificity; Stomach; Testis | 1989 |
6 trial(s) available for simvastatin and Cataract
| Article | Year |
|---|---|
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Denmark; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Norway; Risk Factors; Simvastatin; Sweden; United Kingdom; United States | 2015 |
Lens opacity in patients with hypercholesterolemia and ischaemic heart disease. Electronic lens opacity measurements.
Topics: Adult; Aged; Cataract; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Ischemia; Ophthalmology; Reproducibility of Results; Simvastatin | 1992 |
Long-term safety and efficacy profile of simvastatin.
Topics: Aged; Anticholesteremic Agents; Cataract; Coronary Disease; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Liver; Lovastatin; Male; Middle Aged; Muscles; Simvastatin | 1991 |
Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 years.
Topics: Adult; Aged; Cataract; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lens, Crystalline; Lovastatin; Male; Middle Aged; Simvastatin; Vacuoles | 1990 |
The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
Topics: Aged; Anticholesteremic Agents; Arteriosclerosis; Cataract; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Randomized Controlled Trials as Topic; Simvastatin | 1990 |
Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Cataract; Cholesterol; Cholestyramine Resin; Creatine Kinase; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 1990 |
12 other study(ies) available for simvastatin and Cataract
| Article | Year |
|---|---|
Effects of Statins on the Development of Cataract-the Long Standing Debate.
Topics: Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Ezetimibe; Female; Humans; Male; Simvastatin | 2016 |
Prevention of Cataract by Statins.
Topics: Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Ezetimibe; Female; Humans; Male; Simvastatin | 2016 |
Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats.
Topics: Animals; Apoptosis; Cataract; Gene Expression; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lens, Crystalline; Organ Size; Rats; Rats, Inbred Strains; Simvastatin; Sterols | 2003 |
[Cerebrotendinous xanthomatosis].
Topics: Adult; Brain; Cataract; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Dementia; Diagnosis, Differential; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2007 |
Perspective on cataractogenic potential of HMG-CoA reductase inhibitors.
Topics: Animals; Cataract; Dogs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Rabbits; Rats; Simvastatin | 1995 |
Risk of cataract in patients treated with statins.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cataract; Databases, Factual; Erythromycin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Odds Ratio; Risk; Simvastatin; United Kingdom | 2001 |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
Topics: Adult; Aged; Cataract; Cholesterol; Cholesterol, HDL; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lens, Crystalline; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides | 1992 |
Cataracts by lipid lowering drugs? Three different HMG-CoA reductase inhibitors studied in hypercholesterolemic rabbits.
Topics: Animals; Anticholesteremic Agents; Cataract; Cholesterol; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Pravastatin; Rabbits; Simvastatin | 1992 |
[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
Topics: Adult; Cataract; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Middle Aged; Pravastatin; Refraction, Ocular; Risk Factors; Simvastatin; Visual Acuity | 1991 |
No lens changes caused by simvastatin results from a prospective drug safety study.
Topics: Adult; Aged; Cataract; Drug Evaluation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intraocular Pressure; Lens, Crystalline; Lovastatin; Male; Middle Aged; Photography; Prospective Studies; Simvastatin; Visual Acuity | 1990 |
On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors.
Topics: Animals; Anticholesteremic Agents; Biphenyl Compounds; Cataract; Cholesterol; Dogs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pyrans; Pyrones; Simvastatin | 1990 |
Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up.
Topics: Cataract; Cholesterol; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Simvastatin | 1989 |